Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov
""
MEPS Home Medical Expenditure Panel Survey
FAQ Contact MEPS Espanol Site Map
 
""
spacer
 :: Survey Background
 :: Workshops & Events
 :: Data Release Schedule
 :: Household
 :: Insurance/Employer
 :: Survey Questionnaires
 Data and Statistics
 :: Data Overview
 :: MEPS Topics
 :: Publications Search
 :: Summary Data Tables
 :: MEPSnet Query Tools
 :: Download Data Files
 :: Data Centers
 Communication
 :: What's New
 :: Mailing List
 :: Discussion Forum
 :: Participants' Corner

 


The Medical Expenditure Panel Survey (MEPS) is a set of large-scale surveys of families and individuals, their medical providers, and employers across the United States. MEPS is the most complete source of data on the cost and use of health care and health insurance coverage. Learn more about MEPS.

  ""
Select a profile:
 General user
 Researcher
 Policymaker
 Survey participant
 Media
MEPS Topics
bullet Access to Health Care bullet Health Care Disparities bullet Projected Data
bullet Children's Health bullet Health Insurance bullet Quality of Health Care
bullet Children's Insurance Coverage bullet Medicare/Medicaid/SCHIP bullet State and Metro Area Estimates
bullet Chronic Conditions bullet Mental Health bullet The Uninsured
bullet Dental bullet Minority Health bullet Women's Health
bullet Elderly bullet Obesity    
bullet Health Care Costs bullet Prescription Drugs    
 
What's New Highlights
New Publications
In 2006, U.S. adult consumers spent $130.8 billion on five therapeutic classes of prescription drugs. Expenditures on metabolic agents (drugs to lower blood sugar, reduce cholesterol, or help with other metabolic problems) ranked first at $38.1 billion, followed closely by cardiovascular agents (drugs for reducing high blood pressure and treating heart conditions) at $33.1 billion. The remaining three therapeutic classes that topped expenditures were central nervous system agents ($28.2 billion), psychotherapeutic agents ($17.5 billion), and hormones ($14.0 billion). These purchases accounted for 62.8 percent of the total $208.1 billion spent on all prescribed drug medicines. —From Statistical Brief 232: Statistical Brief 232: The Top Five Therapeutic Classes of Outpatient Prescription Drugs Ranked by Total Expense for Adults Age 18 and Older in the U.S. Civilian Noninstitutionalized Population, 2006

New Tabular Data
MEPS summary tables present 2006 national estimates from the Household Component of the MEPS survey in tabular form. Except for State-Level Medical Expenditure Tables, the following tables are customizable (marked by icon indicating that this table may be customized) and offer the ability to analyze populations by age, gender, race/ethnicity, health insurance status, poverty status, geographic criteria (i.e., metropolitan statistical area and census region), and perceived health status.
  • 2006 Expenditures by Medical Condition
  • 2006 Quality of Care
  • 2006 Access to Care
  • 2006 Expenditures by Health Care Service
  • 2006 State-Level Medical Expenditures


  • New Analytical Tools
    Nationally representative statistics of health care use and expense from the MEPS 2006 year of data collection can now be generated in MEPSnet/HC, the survey's guided, data analysis tool. The online tool offers analytical access to some of the data available on the 2006 MEPS consolidated public use data file without the use of statistical software.

    New Data
    MEPS releases the Panel 10 Longitudinal Data File, a two-year panel file comprises persons representing those who were in the MEPS population (U.S. civilian noninstitutionalized) for all or part of the 2005-2006 period. Variables on this file are useful for developing cross-sectional type estimates for the two-year period.

    To access a list of all the latest items posted on our Web site, visit What's New.

     
    ""